All In Biotech

Drug Trial Radar · NCT07949981

Celiac Versus Splanchnic Neurolysis in Abdominal Malignancies

EFFICACY OF CELIAC PLEXUS NEUROLYSIS VERSUS SPLANCHNIC NEUROLYSIS IN PATIENTS OF ABDOMINAL MALIGNANCIES

Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

60

Actual

Start

Mar 15, 2026

Primary completion

Sep 1, 2026

Study completion Sep 1, 2026

Sponsor

Lead sponsor
Pain Medicine DepartmentAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 20, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Non randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 35 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To compare the analgesic efficacy, patient quality of life and safety profile of celiac plexus neurolysis versus splanchnic neurolysis in patients of abdominal malignancies. Sixty patients suffering from abdominal malignancies. Patients in Group C were administered celiac plexus neurolysis while those in Group S were administered bilateral splanchnic neurolysis. The primary outcome was the pain score measured by the Visual analogue score at two, four and eight and twelve weeks following the procedure. The secondary outcome was improvement in patient quality of life using SF12 questionnaire and safety profile of the procedure.

Conditions

  • Abdominal Malignancy

Interventions

  • Celiac Plexus BlockDrug

    Celiac plexus neurolysis

  • Splanchnic nerve blockDrug

    Splanchnic Neurolysis

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in pain intensity on the Visual Analog Scale (VAS) from baselineTime frame: baseline (pre-procedure), and weeks 2, 4, 8, and 12 after the procedure

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Combined military hospital

    Lahore, Punjab Province, Pakistan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.